Understanding Antimony Resistance in Leishmania amazonensis
Author Information
Author(s): Rubens L. do Monte-Neto, Adriano C. Coelho, Frédéric Raymond, Danielle Légaré, Jacques Corbeil, Maria N. Melo, Frédéric Frézard, Marc Ouellette
Primary Institution: Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil
Hypothesis
What are the molecular mechanisms behind antimony resistance in Leishmania amazonensis?
Conclusion
The study identified molecular markers and mechanisms of antimony resistance in Leishmania amazonensis, similar to those found in Old World species.
Supporting Evidence
- RNA expression profiling revealed overexpression of genes involved in drug resistance.
- MRPA gene overexpression was validated by quantitative real-time RT-PCR.
- Some mutants showed increased expression correlated with gene amplification.
Takeaway
Scientists studied how a tiny bug that causes leishmaniasis can resist a common medicine. They found that some genes in the bug change to help it survive the medicine.
Methodology
The researchers selected L. amazonensis mutants for antimony resistance and analyzed gene expression using DNA microarrays.
Limitations
The study primarily focused on laboratory-selected mutants, which may not fully represent clinical isolates.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website